SB05 CTA (Investigational New Drug) for Phase III cl...
SynCroe has submitted the CTA into Belgium's Federal Agency for Medicines and Health Products(FAMHP) &n... more

SynCoreBio earns the Certificate of The 10th Nationa...
Congratulations!! "Development of a novel small anticancer drug SB01 in Phase I clinical trial" of SynCoreBio is award... more

FDA approved first botanical new drug has launched i...
Veregen® Ointment has launched in Taiwan from October this year, and expending the distribution connection in Hospital, Gen... more

Bio Taiwan 2013
SynCore booth @ Zone I 416   Theme of the Year Establish the cross-strait cooperation platform for biote... more

New General Manager of Syncore, Dr. Muh-Hwuan Su
Tim Lee, Chairman of Sinphar Group (left 2) Mel Muh-Hwuan Su, General Manager of SynCore, since Jnue 1st,2013 (right 2... more